MedTrace Logo

Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System

NCT00955461 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-11-28

No results posted yet for this study

Summary

The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.

Conditions

  • Photodamage
  • Irregular Pigmentation
  • Acne Scars

Interventions

PROCEDURE

RevLite laser treatment

Electro-optic Q-Switched Nd: YAG Laser treatment

PROCEDURE

Fractionated Laser treatment

Sponsors & Collaborators

  • ConBio, a Cynosure Company

    lead INDUSTRY

Principal Investigators

  • Neil Sadick, MD · Sadick Research Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00955461 on ClinicalTrials.gov